Calidi Biotherapeutics, Inc. (CLDI) stock
CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
$0.56−0.04 (-7.07%)
Close on Nov 17, 2026Market cap $1.45MP/E –Yield –
Calidi Biotherapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Calidi Biotherapeutics's enterprise value was -$2.62M on Nov 11, 2026, against $157.23M a year earlier. Over the last 5 years it ranged from -$3.80M to $44.16B, with a median of $1.47B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$2.62M | -102.2% |
| 2025 | Dec 31, 2025 | $119.66M | -94.2% |
| 2024 | Dec 31, 2024 | $2.06B | -80.0% |
| 2023 | Dec 29, 2023 | $10.27B | +27.4% |
| 2022 | Dec 30, 2022 | $8.06B | – |
See a number that looks wrong?